Literature DB >> 1429719

Progesterone blocks cholesterol translocation from lysosomes.

J D Butler1, J Blanchette-Mackie, E Goldin, R R O'Neill, G Carstea, C F Roff, M C Patterson, S Patel, M E Comly, A Cooney.   

Abstract

Fluorescent microscopic examination of fibroblasts cultured with low density lipoprotein (LDL) and progesterone (10 micrograms/ml) for 24 h revealed extensive filipin-cholesterol staining of perinuclear lysosomes. Levels of unesterified cholesterol were 2-fold greater than in fibroblasts cultured with LDL alone. Progesterone strongly blocked cholesteryl ester synthesis. When cellular uptake of LDL was monitored in the presence of 58035, a specific inhibitor of acyl-CoA:cholesterol acyltransferase, excess unesterified cholesterol was not stored in lysosomes. Discontinuation of LDL uptake in conjunction with progesterone washout markedly reversed the filipin-cholesterol staining of lysosomes. Reversal of the lysosomal cholesterol lipidosis was associated with a rapid burst of cholesteryl ester synthesis and a normalization of the cellular levels of free and esterified cholesterol. In contrast to normal cells, progesterone removal from Niemann-Pick C fibroblasts did not reverse the lysosomal cholesterol accumulation of these mutant cultures. The metabolic precursor of progesterone, pregnenolone, also induced extensive accumulation of cholesterol in lysosomes. Other steroids induced less vacuolar cholesterol accumulation in the following decreasing order: corticosterone and testosterone, promegestone, RU 486. The relative inhibition of cellular cholesterol esterification by the steroids paralleled their respective abilities to sequester cholesterol in lysosomes rather than their inhibition of acyl-CoA:cholesterol acyltransferase activity in cell-free extracts. The progesterone-related inhibition and restoration of lysosomal cholesterol trafficking is a useful experimental means of studying intracellular cholesterol transport. A particularly important feature of its utility is the facile reversibility of the steroid-induced block. The lysosomal cholesterol lipidosis established with a hydrophobic amine, U18666A, was not as readily reversed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429719

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae.

Authors:  J B McCabe; L G Berthiaume
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.

Authors:  Ping-Yuan Wang; Pingsheng Liu; Jian Weng; Estelle Sontag; Richard G W Anderson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

3.  Niemann-Pick disease type C in adults.

Authors:  J Imrie; S Vijayaraghaven; C Whitehouse; S Harris; L Heptinstall; H Church; A Cooper; G T N Besley; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

4.  Regio- and stereospecificity of filipin hydroxylation sites revealed by crystal structures of cytochrome P450 105P1 and 105D6 from Streptomyces avermitilis.

Authors:  Lian-Hua Xu; Shinya Fushinobu; Satoshi Takamatsu; Takayoshi Wakagi; Haruo Ikeda; Hirofumi Shoun
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

5.  Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge.

Authors:  Isabelle Coppens; Keith A Joiner
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

6.  Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.

Authors:  Lian-Hua Xu; Shinya Fushinobu; Haruo Ikeda; Takayoshi Wakagi; Hirofumi Shoun
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

7.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease.

Authors:  S C Patel; S Suresh; U Kumar; C Y Hu; A Cooney; E J Blanchette-Mackie; E B Neufeld; R C Patel; R O Brady; Y C Patel; P G Pentchev; W Y Ong
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Localization of cholesterol in sphingomyelinase-treated fibroblasts.

Authors:  M I Pörn; J P Slotte
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

Review 9.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

10.  U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells.

Authors:  S M Sparrow; J M Carter; N D Ridgway; H W Cook; D M Byers
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.